NCT06438445Recruiting
Effects of Royal Jelly Supplementation in Chronic Kidney Disease
Effects of Royal Jelly Supplementation on Inflammation and Cellular Senescence in Chronic Kidney Disease Patients Under Hemodialysis
Source: ClinicalTrials.gov · Last updated 18 May 2026
Brief summary (registry, in English)
The objective of this study is to evaluate the effects of royal jelly on inflammation and cellular senescence in patients with chronic kidney disease (CKD) on hemodialysis (HD).
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- First submitted
- 27 May 2024
- Start date
- 30 Jul 2024
- Primary completion date
- 22 Dec 2026
- Lead sponsor
- Universidade Federal Fluminense
- Diseases
- Chronic kidney disease
- NCT number
- NCT06438445
What you commit to
- Study type: Interventional
- Planned participants: 30
- From 30 Jul 2024 to the primary completion date, 22 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- patients with autoimmune and infectious diseases,
- patients with cancer, liver disease, and AIDS
Other
- pregnant,
- lactating,
- smoker
- patients using antibiotics and antioxidant supplements in the last three months
Who the study is looking for
- patients with CKD undergoing hemodialysis for more than 6 months
- patients with arteriovenous fistula (AVF) as vascular access.
Age in the registry: 18 years to 70 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Denise mafra Coordinator of this site? Confirm its status | Rio de Janeiro | Brazil | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.